These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 34242226)

  • 1. Relevance of diffusion-weighted imaging with background body signal suppression for staging, prognosis, morphology, treatment response, and apparent diffusion coefficient in plasma-cell neoplasms: A single-center, retrospective study.
    Yamada A; Araki Y; Tanaka Y; Otsuki S; Yamada A; Moriyama M; Katagiri S; Suguro T; Asano M; Yoshizawa S; Akahane D; Furuya N; Fujimoto H; Okabe S; Gotoh M; Suzuki K; Saito K; Gotoh A
    PLoS One; 2021; 16(7):e0253025. PubMed ID: 34242226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of whole-body diffusion MRI and conventional radiological assessment in the staging of myeloma.
    Narquin S; Ingrand P; Azais I; Delwail V; Vialle R; Boucebci S; Tasu JP
    Diagn Interv Imaging; 2013 Jun; 94(6):629-36. PubMed ID: 23683788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-treatment staging of multiple myeloma patients: comparison of whole-body diffusion weighted imaging with whole-body T1-weighted contrast-enhanced imaging.
    Squillaci E; Bolacchi F; Altobelli S; Franceschini L; Bergamini A; Cantonetti M; Simonetti G
    Acta Radiol; 2015 Jun; 56(6):733-8. PubMed ID: 24973257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apparent diffusion coefficient maps integrated in whole-body MRI examination for the evaluation of tumor response to chemotherapy in patients with multiple myeloma.
    Bonaffini PA; Ippolito D; Casiraghi A; Besostri V; Franzesi CT; Sironi S
    Acad Radiol; 2015 Sep; 22(9):1163-71. PubMed ID: 26182979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Diffuse Bone Marrow Infiltration Pattern in Monoclonal Plasma Cell Diseases by Quantitative Whole-body Magnetic Resonance Imaging.
    Sun M; Cheng J; Ren C; Zhang Y; Li Y; Wang L; Zhang S; Lin L
    Acad Radiol; 2022 Apr; 29(4):490-500. PubMed ID: 34362664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DCE-MRI to distinguish all monoclonal plasma cell disease stages and correlation with diffusion-weighted MRI/PET-based biomarkers in a hybrid simultaneous whole body-2-[18F]FDG-PET/MRI imaging approach.
    Jamet B; Necib H; Carlier T; Frampas E; Bazin J; Desfontis PH; Monnet A; Bodet-Milin C; Moreau P; Touzeau C; Kraeber-Bodere F
    Cancer Imaging; 2024 Jul; 24(1):93. PubMed ID: 38992707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of PET-CT and magnetic resonance diffusion weighted imaging with body suppression (DWIBS) for initial staging of malignant lymphomas.
    Stéphane V; Samuel B; Vincent D; Joelle G; Remy P; Francois GG; Jean-Pierre T
    Eur J Radiol; 2013 Nov; 82(11):2011-7. PubMed ID: 23932096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review of diffusion-weighted imaging and dynamic contrast-enhanced MRI for multiple myeloma and its precursors (monoclonal gammopathy of undetermined significance and smouldering myeloma).
    Van Den Berghe T; Verstraete KL; Lecouvet FE; Lejoly M; Dutoit J
    Skeletal Radiol; 2022 Jan; 51(1):101-122. PubMed ID: 34523007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Appearance of monoclonal plasma cell diseases in whole-body magnetic resonance imaging and correlation with parameters of disease activity.
    Kloth JK; Hillengass J; Listl K; Kilk K; Hielscher T; Landgren O; Delorme S; Goldschmidt H; Kauczor HU; Weber MA
    Int J Cancer; 2014 Nov; 135(10):2380-6. PubMed ID: 24706394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application value of diffusion weighted whole body imaging with background body signal suppression in monitoring the response to treatment of bone marrow involvement in lymphoma.
    Sun M; Cheng J; Zhang Y; Wang F; Meng Y; Fu X
    J Magn Reson Imaging; 2016 Dec; 44(6):1522-1529. PubMed ID: 27160047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment Response Assessment in Multiple Myeloma: Histogram Analysis of Total Tumor Apparent Diffusion Coefficient based on Whole-body Diffusion-weighted MR Imaging.
    Gao Y; Wang Q; Zhang L; Li S; Liu D; Wang S; Zhu J; Zhang H; Xie S; Xia S; Huang W; Xue H; Li J
    J Magn Reson Imaging; 2024 Sep; 60(3):1051-1060. PubMed ID: 38088500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discriminating Depth of Response to Therapy in Multiple Myeloma Using Whole-body Diffusion-weighted MRI with Apparent Diffusion Coefficient: Preliminary Results From a Single-center Study.
    Wu C; Huang J; Xu WB; Guan YJ; Ling HW; Mi JQ; Yan H
    Acad Radiol; 2018 Jul; 25(7):904-914. PubMed ID: 29373210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Contribution of whole-body magnetic resonance in the diagnostics of monoclonal gammopathy of undetermined significance, multiple myeloma, and the assessment of Durie-Salmon Plus staging system].
    Scudla V; Herman M; Minarík J; Pika T; Hrbek J; Bacovský J; Heinzová V
    Vnitr Lek; 2011 Jan; 57(1):52-60. PubMed ID: 21351663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signal characteristics of focal bone marrow lesions in patients with multiple myeloma using whole body T1w-TSE, T2w-STIR and diffusion-weighted imaging with background suppression.
    Sommer G; Klarhöfer M; Lenz C; Scheffler K; Bongartz G; Winter L
    Eur Radiol; 2011 Apr; 21(4):857-62. PubMed ID: 20853109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole-body magnetic resonance imaging (WB-MRI) with diffusion-weighted whole-body imaging with background body signal suppression (DWIBS) in prostate cancer: Prevalence and clinical significance of incidental findings.
    Kumasaka S; Motegi S; Kumasaka Y; Nishikata T; Otomo M; Tsushima Y
    Br J Radiol; 2022 Mar; 95(1131):20210459. PubMed ID: 34111963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of whole body MRI and dynamic contrast enhanced MRI in the diagnosis, follow-up and evaluation of disease activity and extent in multiple myeloma.
    Dutoit JC; Vanderkerken MA; Verstraete KL
    Eur J Radiol; 2013 Sep; 82(9):1444-52. PubMed ID: 23726124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of combined DWIBS/3D-CE-T1w whole-body MRI in tumor staging: Comparison with PET-CT.
    Manenti G; Cicciò C; Squillaci E; Strigari L; Calabria F; Danieli R; Schillaci O; Simonetti G
    Eur J Radiol; 2012 Aug; 81(8):1917-25. PubMed ID: 21908120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole-body diffusion-weighted MRI for evaluation of response in multiple myeloma patients following bortezomib-based therapy: A large single-center cohort study.
    Zhang Y; Xiong X; Fu Z; Dai H; Yao F; Liu D; Deng S; Hu C
    Eur J Radiol; 2019 Nov; 120():108695. PubMed ID: 31589995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative staging of non-small-cell lung cancer: comparison of whole-body diffusion-weighted magnetic resonance imaging and 18F-fluorodeoxyglucose-positron emission tomography/computed tomography.
    Sommer G; Wiese M; Winter L; Lenz C; Klarhöfer M; Forrer F; Lardinois D; Bremerich J
    Eur Radiol; 2012 Dec; 22(12):2859-67. PubMed ID: 22772365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility of diffusion-weighted imaging with DWIBS in staging Hodgkin lymphoma in pediatric patients: comparison with PET/CT.
    Baranska D; Matera K; Podgorski M; Gorska-Chrzastek M; Krajewska K; Trelinska J; Grzelak P
    MAGMA; 2019 Jun; 32(3):381-390. PubMed ID: 30498885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.